Pharmacodynamic effects of dopamine stratified by race

American Journal of Therapeutics

Volumn 8, Issue 1, 2001, Pages 27-34

  Marinac, Jacqueline S ^a  

^a UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adverse effects; Aldosterone; Bradykinin; Dopamine; Renin; adrenergic agonists

Indexed keywords

ALDOSTERONE; BRADYKININ; CORTICOTROPIN; DOPAMINE; PROLACTIN; RENIN; SODIUM;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD PRESSURE; CAUCASIAN; COMPARATIVE STUDY; DRUG EFFECT; HEART RATE; HUMAN; MALE; NEGRO; URINE;

ADOLESCENT; ADRENOCORTICOTROPIC HORMONE; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALDOSTERONE; BLOOD PRESSURE; BRADYKININ; DOPAMINE; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART RATE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; PROLACTIN; RENIN; SODIUM; URINE;

EID: 0035222049     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/00045391-200101000-00006     Document Type: Article

References (3)

1. Parker S, Carlon GC, Isaacs M, et al: Dopamine administration in oliguria and oliguric renal failure. Crit Care Med 1981;9:630-632.
2. Henderson IS, Beattie TJ, Kennedy AC: Dopamine hydrochloride in oliguric states. Lancet 1980;2:827-828.
3. Seri I: Dopamine and natriuresis: mechanism of action and developmental aspects. Am J Hypertens 1990;3:82S-86S.